Aidapak Recalls Multivitamin Tablets Due to Potential Labeling Errors
Aidapak Services, LLC is recalling multivitamin tablets that may be mislabeled as quetiapine or docusate sodium. The recall covers specific lots distributed in four western states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling mixup. Per the rubric, minor labeling errors and voluntary precautionary recalls without reported injuries are rated as Moderate.
Plain-English summary
Aidapak Services, LLC is recalling 1,045 tablets of Multivitamin/Multimineral, Over The Counter, NDC 37205018581. The recall is due to a labeling mixup where the product may be potentially mislabeled as Quetiapine Fumarate, Tablet, 25 mg, or Docusate Sodium, Capsule, 250 mg.
The affected lots include Pedigree AD32328_8 with an expiration date of 5/9/2014, and Pedigree W002513 with an expiration date of 6/3/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Consumers should check their medication for these specific pedigree codes and expiration dates. If the product matches the description, they should stop using it and contact their pharmacist or the recalling firm for instructions on disposal or replacement.
The recalled product
- Product
- MULTIVITAMIN/MULTIMINERAL Tablet, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 37205018581
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Over-The-Counter
- Hazard
- Affected units
- 1,045
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- MULTIVITAMIN/MULTIMINERAL Tablet has the following codes Pedigree: AD32328_8
- EXP: 5/9/2014
- Pedigree: W002513
- EXP: 6/3/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- SevereAidapak Recalls Multivitamin Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Multivitamin Chew Tablets Recalled for Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Docusate Sodium Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Amantadine HCL Tablets Due to Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Cholecalciferol Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29